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Antimicrobial peptides (AMPs) are important effector molecules in innate immunity. Here 
we briefly summarize characteristic traits of AMPs and their mechanisms of antimicrobial 
activity. Echinoderms live in a microbe-rich marine environment and are known to express a 
wide range of AMPs. We address two novel AMP families from coelomocytes of sea urchins: 
cysteine-rich AMPs (strongylocins) and heterodimeric AMPs (centrocins). These peptide 
families have conserved preprosequences, are present in both adults and pluteus stage larvae, 
have potent antimicrobial properties, and therefore appear to be important innate immune 
effectors. Strongylocins have a unique cysteine pattern compared to other cysteine-rich 
peptides, which suggests a novel AMP folding pattern. Centrocins and SdStrongylocin 2 
contain brominated tryptophan residues in their native form. This review also includes AMPs 
isolated from other echinoderms, such as holothuroidins, fragments of beta-thymosin, and 
fragments of lectin (CEL-III). Echinoderm AMPs are crucial molecules for the understanding 
of echinoderm immunity, and their potent antimicrobial activity makes them potential 
precursors of novel drug leads. 
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Antimicrobial peptides (AMPs) are widespread molecules found both in prokaryotes and 
eukaryotes and provide important protection to hosts against pathogens and/or environmental 
‘invaders’. To date, approximately 2,400 naturally isolated or synthesized AMPs have been 
listed in the Antimicrobial Peptide Database (APD database, 
http://aps.unmc.edu/AP/main.php). The majority of these AMPs are from amphibians, insects, 
mammals, and plants (Wang et al., 2009). There are comparatively few research activities 
throwing light on AMPs in echinoderms. Here, we present an overview of what is currently 
known about echinoderm AMPs, with a special focus on recently identified AMPs from sea 
urchins. Characteristics such as antimicrobial activity, peptide structure, expression profile, and 
biological function in echinoderms are discussed. 
1. Echinoderm host defense 
 
Echinoderms are deuterostome invertebrates, with a phylogenetic position closely related 
to chordates and hemichordates (Kondo and Akasaka, 2012). They are categorized into five 
classes: Crinoidea (sea lilies and feather stars), Ophiuroidea (brittle stars), Asteroidea (sea 
stars), Echinoidea (sea urchins, sand dollars, and sea biscuits), and Holothuroidea (sea 
cucumbers). These animals have a unique morphology that includes a water vascular system 
and a pentamerously symmetrical body shape in the adults. All living echinoderms are marine 
species and occupy habitats from the intertidal zone to the deep sea. These environments are 
rich in bacteria, fungi, viruses, and parasites, and many are potentially pathogenic to 
echinoderms.  Echinoderms have evolved in complex means to overcome these challenges as 
was first illustrated from the annotation of the purple sea urchin genome (Rast et al., 2006).   
Echinoderms have an innate immune system, but as all other invertebrates they lack a 
vertebrate-type adaptive immune system (Smith and Davidson, 1992). However, their ability 
to reject non-self tissues has been documented for several echinoderm species (reviewed by 
Smith et al. 2010 and Smith et al. 2006).  Many of their immune activities occur in the 
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coelomic fluid, which is a complex fluid containing minerals, proteins, and suspended cells 
called coelomocytes. These coelomocytes are critical immune mediators and are involved in 
the response against pathogens, injuries, and foreign substances (Smith et al., 2010; Smith et 
al., 2006). In general there are four morphologically different types of coelomocytes in 
echinoderms: phagocytes, vibratile cells, colorless and red spherule cells. However, 
Asteroidea and Ophiuroidea lack red spherule cells, and Crinoidea lack vibratile cells 
(reviewed by Ramirez-Gomez and Garcia-Arraras, 2010). Phagocytes constitute the most 
abundant coelomocyte type in the coelomic fluid (reviewed by Smith et al., 2010). Based on 
morphology, phagocytes can be categorized into three subtype populations. One subset 
consists of large discoidal phagocytes that have radially oriented actin bundles distributed 
throughout the cortex from the perinuclear region to the periphery (Henson et al., 2003; 
Henson et al., 1999). Another subset consists of large polygonal phagocytes that have actin 
bundles that are oriented across the cell creating a polygon cell shape (Henson et al., 1999). 
The third subset are smaller cells called small phagocytes (Gross et al., 2000) that are always 
present in filopodial form (Brockton et al., 2008). It is known that the sea urchins, 
Strongylocentrotus droebachiensis and S. purpuratus, are able to clear injected bacteria 
quickly from their coelomic fluid (Plytycz and Seljelid, 1993; Yui and Bayne, 1983). In 
addition, the different types of coelomocytes differ in their activity against microbial 
intruders. Phagocytic amoebocytes (herein referred to as phagocytes) and red spherule cells 
from Paracentrotus lividus exert a higher antibacterial activity against Gram-negative marine 
bacteria than the other populations of coelomocytes (Gerardi et al., 1990). When erythrocytes 
are opsonized by molecules in the coelomic fluid, this enhances the capacity of phagocytes 
from S. nudus to take up the erythrocytes (Ito et al., 1992). Several humoral factors are 
involved in defense processes such as clotting, opsonization, encapsulation, cell lysis, and 
wound healing (Gross et al., 1999). For example, the coelomic fluid from four sea urchin 
 5 
species, Anthocidaris crassispina, Pseudocentrotus depressus, Hemicentrotus pulcherrimus, 
and Holothuria polii, has hemagglutinating activity against mammalian erythrocytes 
(Canicattì and Parrinello, 1985; Ryoyama, 1974). An agglutinin from the coelomic fluid of 
the sea urchin P. lividus not only agglutinates animal erythrocytes but also promotes adhesion 
of the autologous coelomocytes (Canicatti et al., 1992). Echinoderm lectins, which are 
carbohydrate binding proteins, function to bind erythrocytes (Matsui et al., 1994), agglutinate 
bacteria (Kamiya et al., 1992), and assist in cell adhesion (Ozeki et al., 1991). In addition to 
AMPs, the innate immune system of echinoderms also has a number of antimicrobial 
components such as lysozyme, which play an important role in the echinoderm defense 
system. Generally, lysozymes show antimicrobial functions against Gram-positive bacteria 
and have been detected in asteroids (Bachali et al., 2004; Jollès and Jollès, 1975), echinoids 
(Shimizu et al., 1999), and holothuroids (Cong et al., 2009). A larval lysate of P. lividus has 
lysozyme-like and antibacterial activity against marine bacteria (Stabili et al., 1994). It is 
possible that lysozyme, AMPs and other antimicrobial factors act synergistically to provide an 
effective defense against microbial infections.  
The first echinoderm genome to be completely sequenced was the genome of S. purpuratus 
(Sodergren et al., 2006).  The sequence revealed a complex immune gene repertoire, indicating 
that sea urchins have an astonishingly high diversity of immune molecules (Hibino et al., 2006; 
Rast et al., 2006). Analysis of the S. purpuratus genome has uncovered an extreme expansion 
of several immune recognition receptor families. The genome sequence revealed 253 Toll-like 
receptor (TLR) genes (Buckley and Rast, 2012), more than 200 NACHT domain-LRR (NLR) 
genes and 218 scavenger receptor genes (Rast et al., 2006). Another large putative immune 
response gene family encodes the Sp185/333 protein family, which was initially identified by 
analyzing transcripts from LPS challenged sea urchins (Nair et al., 2005; Terwilliger et al., 
2006). Of 171 genes from the Sp185/333 family that were sequenced, there were 121 unique 
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gene sequences, and 689 cDNA sequences (Terwilliger et al., 2006; 2007) resulted in a total of 
51 different element patterns (Buckley and Smith, 2007); reviewed by Smith (2012). 
Furthermore, the S. purpuratus genome contains homologues of the vertebrate complement 
protein C3 and factor B, called SpC3 and SpBf, respectively (reviewed by Smith et al., 2001). 
They were the first complement components to be identified in an invertebrate. The expression 
of the gene Sp064 that encodes SpC3 is upregulated after LPS challenge (Clow et al., 2000) 
and shows typical C3 function by binding to both methylamine and yeast and functioning as an 
opsonin (Clow et al., 2004). In addition, two transcripts from S. purpuratus encode putative 
complement proteins with domains that are also present in C6 and C7 (Multerer and Smith, 
2004). Their deduced proteins might participate in the terminal complement pathway or act as 
complement regulatory proteins in sea urchins.  
Although the recent acquisition of genetic information of echinoderms, such as the S. 
purpuratus genome sequence, allows us a glance at the complexity of the echinoderm immune 
system, we are far from understanding the immune system of the echinoderms. This is specially 
true for immune effectors such as antimicrobial compounds, which are understudied and very 
poorly understood. Considering the intriguing number and diversity of species in the 
Echinoderm phylum, their microbe-rich habitat, and mostly untapped genetic information, it is 




While the amino acid composition which defines the structure of AMPs is diverse, some 
basic features seem to be common. AMPs are relatively short amino acid sequences, usually 
less than 100 amino acids (Ganz, 2003; Maroti et al., 2011), and according to the APD database, 
the average length of all registered peptides is around 32 residues with an average net positive 
charge of 3.18 (Wang et al., 2009).  AMPs commonly contain many positively charged residues 
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such as arginine and lysine, which result in the net positive charge (Hancock and Sahl, 2006; 
Zasloff, 2002). Most antimicrobial peptides fold into amphipathic structures, which reflect the 
relative abundance and polarization of hydrophobic and hydrophilic domains in their structural 
conformation. These fundamental features of AMPs also determine their antimicrobial 
properties such that the hydrophobic regions enable water-soluble AMPs to interact with the 
hydrophobic lipid bilayer of bacterial cell membranes (Brogden, 2005; Matsuzaki, 1999), 
which are known to be predominantly composed of phosphatidylglycerol, cardiolipin, or 
phosphatidylserine, resulting in a negative net charge on their outer leaflet (Yeaman and Yount, 
2003). Studies on both artificial model membranes and bacterial membranes have shown that 
AMP-membrane interaction is initiated by electrostatic attraction (Scott et al., 1999; Silvestro 
et al., 1997; Zhao et al., 2001), followed by attachment (Heller et al., 1999; Huang, 2000; Wu 
et al., 1995), insertion (Lee et al., 2004; Yang et al., 2001), which leads to the loss of membrane 
integrity (Lee et al., 2004) and ion leakage through transmembrane pores or detergent-like 
solubilization of the cell membrane. Several models have been proposed to describe the 
mechanisms of action involved in AMP-dependent membrane damage that occurs when the 
AMP concentration reaches a certain threshold of a peptide/membrane lipid ratio.  The AMPs 
form peptide helices that insert into the membrane either as a toroidal pore, a barrel stave, or a 
carpet model. The ‘toroidal pore’ model suggests that the lipid layer bends continuously and 
associates with the hydrophobic region of peptide forming the pore (Matsuzaki et al., 1996; 
Matsuzaki et al., 1998). According to the ‘barrel-stave model’, peptide helices insert into the 
membrane as parallel staves and form barrel-like pores (Cantor, 2002; He et al., 1995; Lee et 
al., 2004; Yang et al., 2001). In the ‘carpet model’, peptides show ‘detergent-like’ activity and 
disrupt the bilayer by forming micelles (Bolintineanu and Kaznessis, 2011; Ladokhin and White, 
2001; Shai, 1999). In addition, the pores formed by AMPs in supported lipid bilayers can 
expand in size from the nano to micrometer scale resulting in a point of complete membrane 
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disintegration (Rakowska et al., 2013). Some AMPs are able to translocate across the membrane 
and interact with intracellular targets. The mammalian proline-rich AMPs PR-39 and 
indolicidin inhibit protein and/or DNA synthesis in Escherichia coli (Boman et al., 1993; 
Subbalakshmi and Sitaram, 1998). In addition, buforin II and tachyplesin can bind nucleic acids 
(Park et al., 1998; Yonezawa et al., 1992); histatins reduce enzyme activity (Kavanagh and 
Dowd, 2004); and mersacidin inhibits cell wall synthesis (Brotz et al., 1998). Furthermore, 
AMPs are typically active against microbes in a dose-dependent manner, whether they act on 
the membrane or intracellular targets (Jang et al., 2010; Mochon and Liu, 2008; Muñoz et al., 
2012; Romani et al., 2013; Vasudevan et al., 2008). 
As a group of crucial immune-related molecules in multicellular organisms, it is not 
surprising that some AMPs have multiple roles, which not only have a direct antimicrobial 
function but also act indirectly as modulators of innate immunity, such as inducing chemokine 
production and influencing the processes of apoptosis, angiogenesis, and wound healing 
(Guilhelmelli et al., 2013; Hancock and Sahl, 2006). For example, magainin and gomesin 
induce apoptosis by increasing the activity of caspase-3, which is a frequently activated death 
protease (Cruz-Chamorro et al., 2006; Paredes-Gamero et al., 2012). PR-39 is involved in the 
regulation of angiogenesis (Li et al., 2000), promotion of wound repair (Gallo et al., 1994; Shi 
et al., 1996), and modulation of cytokine production (Veldhuizen et al., 2014). Therefore, such 
moonlighting functions should always be considered when AMPs are discovered or used as 
drug leads.  
AMPs play an important role in host defense and might therefore serve as models for 
pharmaceutical drug leads. The pharmaceutical industry has shown a growing interest in AMPs, 
due to their attractive properties, such as high target specificity, high potency, and minimal 
toxicity/side-effects to the patient (Góngora-Benítez et al., 2014; Northfield et al., 2014). 
Examples of AMPs that have entered clinical trials are the lactoferricin derivative LTX-109 
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and the indolicidin variant CP-226 called omiganan (Hancock and Sahl, 2006). Historically, 
AMPs have mainly been isolated from mammals, insects and plants. In recent years, however, 
the focus of bioprospecting activities has been shifting towards marine resources. Echinoderms, 
which have approximately 7,000 extant species and contribute significantly to marine 
biodiversity, are therefore expected to be a valuable source of bioactive and therapeutic peptides.  
What we currently know about some of the AMPs in echinoderms and their activities is the 
focus of the remainder of this review. 
3. AMPs in Echinoderms 
 
The first completely sequenced genes encoding AMPs in echinoderms were the 
strongylocins, which are expressed in the coelomocytes of the green sea urchin, S. 
droebachiensis (Li et al., 2008). This family of peptides includes two native members, named 
SdStrongylocins 1 and 2, and each has putative isoforms (SdStrongylocins1b and 2b). Native 
SdStrongylocin 1 is a peptide of 48 amino acids of 5.6 kDa with an isoelectric point (pI) of 
9.34, while native SdStrongylocin 2 has 51 amino acids, is 5.8 kDa with a pI of 9.65. The 
SdStrongylocins display potent activity against both Gram-positive and Gram-negative 
bacteria at minimal inhibitory concentrations (MIC) of 1.3 – 2.5 μM. Listonella anguillarum, 
a marine fish pathogen, is especially susceptible to SdStrongylocin 2. The peptides are 
cysteine rich, with six cysteines distributed throughout the sequence (Fig. 1A). Cysteine-rich 
AMPs have been discovered in many species from both the animal and plant kingdoms. The 
number of cysteines and their location pattern in the sequence determines the formation of 
disulfide bridges and the conformational structure of the peptides, which influences the 
antimicrobial activity of the AMPs (Selsted and Ouellette, 2005). The human native 
neutrophil α-defensin, which has six cysteines, is active against viral or bacterial targets but 
loses this activity when linearized (Daher et al., 1986; Mandal and Nagaraj, 2002). A 
cysteine-rich AMP from a legume that is correctly folded with regard to the disulfide bonds is 
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not only dramatically more active against bacteria but also more stable than peptides that are 
alternatively folded with incorrect disulfide bonds (Haag et al., 2012). Strongylocins have a 
unique cysteine arrangement pattern compared to cysteine location pattern of other cysteine 
rich AMPs (Table 1). The cysteines form three disulfide bonds, which may influence the 
antimicrobial activity of the peptide and protect the molecule from proteolytic degradation 
during biosynthesis in the coelomocyte and subsequent function upon secretion in the 
presence of microbes (Li et al., 2008; Selsted and Ouellette, 2005). Although the disulfide 
bonds in the stronglocins are important for the peptide activity, the exact orientation of the 
disulfide bonds that function in the native peptides is, however, currently unknown. 
Homologous peptides of SdStrongylocin are also expressed in the purple sea urchin, S. 
purpuratus, and named SpStrongylocins 1 and 2 (Li et al., 2010a). Recombinant 
SpStrongylocins (rSpStrongylocins) are active against both Gram-positive and Gram-negative 
bacteria; however, membrane integrity studies showed that rSpStrongylocins 1 and 2 do not 
enhance the permeability of the bacterial membrane (Li et al., 2010a).  This suggests that 
SpStrongylocins may have intracellular targets or affect microbial killing in other ways. 
Based on the identical cysteine location pattern and high sequence similarity among the 
SdStrongylocins and SpStrongylocins, especially between SdStrongylocin 1 and 
SpStrongylocin 1, it is likely that the strongylocins employ a similar mode of antimicrobial 
action.  
Another set of AMPs identified from the coelomocytes of S. droebachiensis are centrocins 
1 and 2 (Li et al., 2010b). The native forms of two similar peptides isolated from S. 
droebachiensis were named Centrocin 1 (4.5 kDa) and Centrocin 2 (4.4 kDa), respectively. 
Subsequent cDNA analyses revealed an isoform, which is closely related to Centrocin 1, 
therefore named Centrocin 1b. Centrocins 1 and 2 are cationic peptides with pIs of 10.06 and 
9.69, respectively, and are active against both Gram-positive and Gram-negative bacteria at a 
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MIC range of 1.3 – 2.5 μM. The centrocins are heterodimeric peptides which consist of a 
heavy chain (30 aa) and a light chain (12 aa) that are linked by an internal disulfide bond (Fig. 
1B and 1C). The heavy chain of the centrocins contributes to the antimicrobial activity of the 
heterodimer, while the light chain does not have any detectible activity or influence the 
activity of the heavy chain against microbes (Li et al., 2010b). Although the light chain of 
centrocins alone is inactive against microbes, the formation of a heterodimeric structure in the 
native centrocins infers that the light chain may aid in stabilization of the molecules and make 
the peptides more resistant to attack by proteases (Li et al., 2010b). Other dimeric AMPs that 
have been identified from other animals include distinctin from tree frog, Phyllomedusa 
distincta  (Batista et al., 2001), cryptdin-related sequence (CRS) peptides from mouse, Mus 
musculus (Hornef et al., 2004), cathelicidin CAP11 from neutrophils of guinea pig, Cavia 
porcellus (Yomogida et al., 1996), PMAP36 from pig, Sus scrofa (Scocchi et al., 2005), 
dicynthaurin and halocidin from the tunicate, Halocynthia aurantium (Jang et al., 2002; Lee et 
al., 2001). The dimeric structure of these types of AMPs influences antimicrobial activity, 
solubility, and protease resistance (Dempsey et al., 2003; Dewan et al., 2009; Hara et al., 
2001; Lee et al., 2008; Liu et al., 2010; Shin et al., 2010).  
Analysis of the deduced sequences of strongylocins and centrocins (Fig. 1) shows that the 
putative precursor molecules have preprosequences and that the centrocins have an interchain 
region between the heavy chain and the light chain (Li et al., 2010a; Li et al., 2010b; Li et al., 
2008). AMPs are often derived from larger precursor molecules (Zasloff, 2002), and hence, 
the AMPs become biologically active mature molecules after one or more post-translational 
modification steps that include the removal of a presequence (also called a signal sequence) 
and/or prosequences, hydroxylation, halogenation (usually bromination), and glycosylation 
(Wang, 2012). Presequences, functioning as signal sequences, are likely important for 
targeting the ribosome to the rough endoplasmic reticulum (ER) and for guiding protein 
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translocation across the ER membrane (Coleman et al., 1985; Reddy et al., 2004). The 
presequences are highly conserved in SdStrongylocin 1, SpStrongylocins 1 and 2, but have a 
different sequence in SdStrongylocin 2; however, all are hydrophobic (Fig. 1). In addition, the 
centrocins (including the putative form from S. purpuratus) share a conserved presequence 
(Li et al., 2010b), which differs from the strongylocin presequences. Three sorts of 
presequences in sea urchin AMPs are conserved within each family, but divergent among 
them. This indicates that these presequences might have different evolutionary origins and 
exert various pathways for intracellular translocation. Prosequences of strongylocins and 
centrocins contain several negatively charged amino acids, which make these AMP precursors 
less cationic. Many prosequences are known to inhibit the activity of the precursor until they 
are cleaved (Neurath, 1989); however, prosequences may also act as intramolecular 
chaperones, which aid in proper folding of the mature AMP.  Prosequences with a net 
negative charge, such as in strongylocin and centrocin prosequences, likely silence the 
activity of the AMPs in the precursor form and prior to activation in the coelomocyte. 
Therefore, it is not surprising that preprosequences are crucial for translocation and 
inactivation of precursor molecules until AMPs acquire mature functions by post-translational 
modifications.    
Brominated natural products are broadly distributed in marine organisms, but few are 
peptides. The aromatic amino acid tryptophan contains a heterocyclic indole group with 5 
possible carbon positions (carbon number 2, 4, 5, 6, and 7) where a hydrogen can be 
substituted with a bromine atom. Most natural brominated peptides isolated contain either 2-, 
5-, or 6-bromothryptophan residues (Bittner et al., 2007). Protein containing brominated 
tryptophan is resistant to degradation by proteases (Shinnar et al., 2003). One example is 
styelin D, a 32-residue long AMP isolated from the tunicate Styela clavata, which contains a 
6-bromotryptophan residue in its sequence. The native peptide exerts antibacterial activity 
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against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) at a range of pH 
and salinity. However, a synthesized version of styelin D with a non-brominated tryptophan 
shows decreased activity at low pH and/or high salinity (Taylor et al., 2000). This suggests 
that the post-translational modification of styelin D may preserve the antimicrobial activity at 
low pH and/or high salinity. Similarly, the bromotryptophan-containing cathelicidins, isolated 
from the Atlantic hagfish (Myxine glutinosa), are likely to be less susceptible to proteolysis 
(Uzzell et al., 2003). Hedistin is another brominated AMP, isolated from the coelomocytes of 
the marine annelid Nereis diversicolor (Tasiemski et al., 2007), and here the non-halogenated 
synthetic peptide is equally active as the native peptide.  This suggests that bromination is the 
basis for making the peptide more resistant to proteases rather than being required for the 
antimicrobial activity. Protease resistance would extend the activity in vivo and thereby 
sustain the antimicrobial activity. SdStrongylocin 2 also contains a bromotryptophan residue 
and shows potent activity against bacteria (Li et al., 2008); however, the recombinant 
SpStrongylocin 2 also shows antibacterial activity, even though the tryptophan residue is not 
brominated (Li et al., 2010a). Likewise, the centrocins have a bromotryptophan residue in 
their heavy chain, which, if not brominated, does not alter the microbicidal activity of these 
peptides (Bjorn et al., 2012). Although we cannot exclude the possibility that the bromination 
of the native dimeric centrocins and SdStrongylocin 2 may have some influence on their 
antimicrobial activity, this post-translational modification may have effects similar to that 
suggested for hedistin and the hagfish cathelicidins, which is to protect the peptides from 
protease degradation. 
Sea urchins have four major populations of coelomocytes based on morphological 
differences (reviewed in Smith et al., 2010). Phagocytes constitute the majority of 
coelomocytes and are divided into three subtypes; however, cell separation techniques limit 
purification of the subtypes. Recent results of AMP gene expression from S. droebachiensis 
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show that transcripts of SdStrongylocin 1 are present in the phagocyte class of coelomocytes 
and in a fraction that is composed of a mixture of vibratile and colorless spherule cells. 
Furthermore, transcripts of SdStrongylocin 2 are present in both phagocytes and red spherule 
cells, while transcripts of centrocin 1 are only present in phagocytes in cytoplasmic vesicles 
(Li et al., 2014). Phagocytes challenged with co-cultured bacteria in vitro, resulted in 
centrocin 1 attaching to these phagocytosed bacteria inside the phagolysosomes. These studies 
suggest that sea urchin AMPs exert their antibacterial activities inside of coelomocytes and 
not in the coelomic fluid. Therefore, presequences direct the precursors of centrocin to the 
lysosomes. This is in agreement with previous observations where antibacterial activity was 
detected in extracts of coelomocytes and not in extracts of cell-free coelomic fluid (Haug et 
al., 2002).  
Sea urchin eggs are embedded in a jelly coat composed of polysaccharides and 
glycoproteins (Jondeung and Czihak, 1982), which, in combination with maternal molecules, 
provides immune protection to the embryos (Kitazume et al., 1994). During development, sea 
urchin embryos and larvae face pathogenic challenges in the marine environment once they 
emerge from the fertilization envelope as multi-cellular organisms with an ectodermal body 
wall that quickly develop the digestive tract. Transcripts of the gene Sp064, which encodes a 
homologue of complement C3 that functions as an opsonin (Clow et al., 2004), is present in 
unfertilized eggs and throughout embryogenesis (Shah et al., 2003). Phagocytosis of injected 
yeast cells has been observed for the secondary mesenchyme cells at the mid gastrula stage of 
Lytechinus variegatus (Silva, 2000), and pinocytosis occurs in the cells lining the stomach 
and intestine of the pluteus larvae of L. pictus (Huvard and Holland, 1986).  The question is: 
when do AMPs contribute to sea urchin larval innate immunity? In S. droebachiensis, 
transcripts of SdStrongylocins are present in the early pluteus stage whereas transcripts of 
centrocin 1 are detected in the mid pluteus stage (Li et al., 2014). Moreover, centrocin 1 is 
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mainly present in blastocoelar cells at coelomic vesicles and sacs around the stomach and 
esophagus, and also in a few blastocoelar cells that patrol close to the ectodermal walls in 
some arms. Thus, AMPs have a crucial role in immunity, not only in adult sea urchins but 
also in larvae.   
There are several other AMPs that have been identified in echinoderms (Table 2). A 
number of partial peptide sequences that show antimicrobial activity were identified from a 
coelomocyte extract from the sea star Asterias rubens, including fragments of histone H2A, 
actin and filamin A (Maltseva et al., 2007). These peptides, which have a molecular mass of 
1.8 - 2.4 kDa, are highly cationic with a predicted pI ranging from 11.3 to 12.3. Four other 
AMPs were also detected in A. rubens coelomocytes, but the sequences were not identified. A 
coelomic fluid extract of the sea cucumber Cucumaria frondosa was purified by molecular 
sieve chromatography, and an unsequenced AMP of about 6 kDa was detected (Beauregard et 
al., 2001). Two peptide fragments, called holothuroidins 1 and 2, from the sea cucumber H. 
tubulosa have activity against human pathogens, with MICs in the mM range (Schillaci et al., 
2013).  Helical wheel analysis indicated that the holothuroidins probably adapt to an α-helical 
structure with considerable amphipathic character. Synthetic holothuroidins also inhibit 
biofilm formation of three bacterial strains, S aureus, S. epidermidis, and Pseudomonas 
aeruginosa. Another synthetic peptide, corresponding to the α-helical region of CEL-III (a 
fragment of a lectin isolated from the sea cucumber C. echinata) shows strong antibacterial 
activity against S. aureus and Bacillus subtilis through a marked permeabilization of the 
bacterial cell membrane (Hatakeyama et al., 2004; Hisamatsu et al., 2008). Recently, peptides 
of <5 kDa, which might be fragments of beta-thymosin, were detected in coelomocyte 
extracts of the sea urchin P. lividus, and show activity against Gram-positive and Gram-
negative bacteria and inhibited the formation of biofilms (Schillaci et al., 2010; Schillaci et 
al., 2012).  Although these preliminary investigations only cover very few echinoderm 
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species, the exciting findings infer that echinoderms deserve more efforts to discover new 
active compounds.  
4. Summary 
 
In the last few decades, thousands of AMPs have been characterized, and some of their 
killing mechanisms and other functions have been addressed. In order to identify potent 
antimicrobial agents, exploration has shifted from terrestrial species towards marine species 
that inhabit regions from the intertidal zone to the deep sea. Echinoderms, being the second 
largest group of deuterostomes, constitute a huge potential source for new bioactive peptides 
that may lead to new drugs. In this review, we have provided an overview of antimicrobial 
peptides found in echinoderms. A broad range of bioactivities have been attributed to AMPs, 
including bactericidal, fungicidal, anti-inflammatory activity, wound healing, and inhibition 
of biofilm formation. In addition, AMPs from echinoderms have provided insights into the 
functional importance of some post-translational modifications, and unique functional 
domains and conformational structures, which may benefit the design of new peptide drugs, 
such as proteolytic resistant AMPs, AMP mimetics, chimeric AMPs, AMP congeners, AMP 
conjugates, and immobilized AMPs (Brogden and Brogden, 2011).  
AMPs are crucial effector molecules that are essential for effective echinoderm innate 
immunity. Li et al. (2014) demonstrated that AMPs appear and function from the early 
developmental stages throughout the remainder of the sea urchin lifespan. Although AMPs act 
as downstream effector molecules in animal immunity, mammalian AMPs are also considered 
as immunoregulatory molecules (Hancock and Sahl, 2006; Hilchie et al., 2013). However, 
there is currently no evidence to suggest that echinoderm AMPs function to modulate the 
expression of chemokines/cytokines during echinoderm immune defense. The complexity of 
immune receptors in echinoderms has been unveiled by the analysis of the genome of S. 
purpuratus (Rast et al., 2006). This complexity raises many questions such as how immune 
 17 
receptors can recognize and distinguish various pathogens, trigger signaling pathways, and 
activate effector molecules such as AMPs.  Future work will help us to address questions of 
AMP activities and to better understand the role of AMPs in echinoderm immunity. 
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Table 1.  Cysteine location patterns in AMPs containing 6 cysteine residues.  
Peptide family Cysteine location patterns a Animals 
Buthinin, Cycloviolacins, Circulins C – C – C – C – C – C  Insects, plants  
Thionins, Phoratoxin,  CC – C – C – C – C  Plants 
Knottin-type AMPs, PaAMPs C – C – CC – C – C Plants 
Tachystatins C – C – CC – C – C  Horseshoe crab 
Strongylocins C – C – C – CC – C  Echinoderms 
Alpha-defensins C – C – C – C – CC Mammals 
Βeta-defensins C – C – C – C – CC Mammals, birds 
a
 Adjacent double cysteine residues are boxed. Information regarding cysteine arrangements in the different 
peptides was obtained from the Antimicrobial Peptide Database (Wang et al., 2009). 





Table 2.  Antimicrobial peptides and proteins characterized in echinoderms.  
 
Class and genus Origin Peptides MW (kDa) Reference 
Asteroidea 
 
    
Asterias rubens Coelomocytes Fragments of Actin, 
Histone H2A, and 
filamin A a 
1.8-2.4 Maltseva et al., 2007 
 Coelomocytes Peptides 2.6-4.7 Maltseva et al., 2007 
Echinoidea 
 




Coelomocytes Fragments of ß-
thymosin a 
1.3-2.3 Schillaci et al., 2010 
Strongylocentrotus 
droebachiensis 
Coelomocytes SdStrongylocins 5.6-5.8 Li et al., 2008 
 
 
Coelomocytes Centrocins 4.4-4.5 Li et al., 2010b 
S. purpuratus Coelomocyte 
cDNA 
SpStrongylocins b 5.6-6.1 Li et al., 2010a 
Holothuroidea 
 




Whole body Fragments of CEL-
III protein a, c 




Coelomic fluid Sequence unknown ~ 6 Beauregard et al., 2001 
Holothuria 
tubulosa 
Coelomocytes Holothuroidins a, c 1.4-1.5 Schillaci et al., 2013 
 
a Putative AMPs, derived from larger precursor molecules. 
b Recombinantly produced peptides. 








                                                                                                                                                
SdStrongylocin  1a  MDLRSASLVFLVVVMVLSYSMAAPLDADNDEEMEE 
SdStrongylocin  1b  MDLRSASFVFLVVVMVLSYSMAAPLDADNDEEMEE 
SpStrongylocin   1  MDLRSASLVFLVVVMVLSYSMAAPLDADNDEEMEE 
 
 
SdStrongylocin  1a  IFGSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPQT  
SdStrongylocin  1b  IFGSIYHRECVKKNRCETVNGNKTCKELTCCRAVIFRHERPEVCRPQT  




                                                                                                                                        
SdStrongylocin  2a  MNIRKGSLMLLITMMILSQAVASRFLDEADEDEHLMEA 
SdStrongylocin  2b  MNIRKGSFMLLITIVILSQAVASRFLDEADEDEHLMEA 
SpStrongylocin   2  MDLRSASLVFLVVAMVLSYSMAESFEVDDAVMEEL--- 
 
                                    * 
SdStrongylocin  2a  WNPFKKIANRNCYPKTTCETAGGKKTCKDFSCCQIVLFGK--KTRAKCTVVTS   
SdStrongylocin  2b  WNPFKKIAHRNCYPKQECETAGGKKTCKDFSCCQIVLFGK--KTRAKCTVVTMS  




                                                                                  
Centrocin 1a   MMIKVALVLCAIVATSMVCAKDFEEQDALDALLNMMLPEEVASPDDAVALQ    
Centrocin 1b   MMIKVALVLCAIVATSMVCAKNFEEQDALDTLLNMMLSEEVASPDDAVALQ    
Centrocin 2    MMIKVALVLCAIVATSMVCAKNFEEQDALDTLLNLMLSEEAASP-DAVALQ    
                
                *                                                                                      
Centrocin 1a   GWFKKTFHKVSHAVKSGIHAGQRGCSALGFSPEEARVKILTAIPEMREEDLSEEDLRGACAAAHALGR   
Centrocin 1b   GWFKKTFHKVSHAVKSDIHAGQRGCSALGFSPEEARVKILTAFPEMKEEDLTEEGVRAVCAGAHALGR   




                             * 
Centrocin 1a   GWFKKTFHKVSHAVKSGIHAGQRGCSALGF 
                                       | 
                                  DLRGACAAAHAL 
 
                             * 
Centrocin 2    SWFSRTVHNVGNAVRKGIHAGQGVCSGLGL 
                                       | 
                                  DLRAICAGAHAL 
 
Figure 1.  Alignment of SdStrongylocins from S. droebachiensis and SpStrongylocins from 
S. purpuratus (A), centrocins from S. droebachiensis (B), and the structure of centrocins (C).  
The preprosequences (or prosequence) are boxed.  The first amino acid in the mature 
SdStrongylocin 2, SpStrongylocin 2 and the second amino acid in the mature centrocins are  
brominated tryptophans (*).  Cysteines are shaded in black. The gray shaded and boxed C-








heavy chain light chain prosequence (interchain) 
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